PCOS Renamed PMOS: Understanding the Shift in Diagnosis for a Common Hormonal Disorder

The medical community is renaming Polycystic Ovary Syndrome (PCOS), the most common hormonal disorder affecting women, to Polyendocrinometabolic Ovarian Syndrome (PMOS). This change reflects a broader understanding of the condition's complex metabolic and endocrine impacts. Nadine Schunke, who was diagnosed with the syndrome at age 31, speaks of her experience using "one" instead of "I," highlighting a sense of shared struggle among those affected. She notes that previous advice, such as dietary changes or taking birth control pills, offered little relief. According to the World Health Organization (WHO), PMOS affects approximately one in ten women of childbearing age. However, estimates suggest that two-thirds of these individuals remain undiagnosed worldwide. The renaming signifies a shift in medical perspective, acknowledging the syndrome's multifaceted nature beyond just ovarian cysts. This rebranding aims to improve diagnosis and understanding of a condition that impacts a significant portion of the female population, many of whom are unaware of their diagnosis.

“

Eat less.